Covista Yönetim
Yönetim kriter kontrolleri 2/4
Covista CEO'su Steve Beard, Sep2021 tarihinde atandı, in görev süresi 4.67 yıldır. in toplam yıllık tazminatı $ 17.24M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5.8% maaş ve 94.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.08% ine doğrudan sahiptir ve bu hisseler $ 45.49M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.1 yıl ve 7.6 yıldır.
Anahtar bilgiler
Steve Beard
İcra Kurulu Başkanı
US$17.2m
Toplam tazminat
| CEO maaş yüzdesi | 5.80% |
| CEO görev süresi | 4.7yrs |
| CEO sahipliği | 1.1% |
| Yönetim ortalama görev süresi | 4.1yrs |
| Yönetim Kurulu ortalama görev süresi | 7.6yrs |
Son yönetim güncellemeleri
Recent updates
Yeni Anlatı • Apr 22
Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential
Catalysts About Covista Covista is a health care education provider focused on training nurses, physicians, veterinarians and behavioral health professionals at scale. What are the underlying business or industry changes driving this perspective?
Yeni Anlatı • Apr 08
Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis
Catalysts About Covista Covista provides higher education programs focused on health care and related professional fields. What are the underlying business or industry changes driving this perspective?
Yeni Anlatı • Mar 24
Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes
Catalysts About Covista Covista focuses on large scale health care education programs serving nursing, medical, veterinary and allied health students across the United States. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Mar 13
Covista: A Mispriced Bet On The Healthcare Worker Shortage
Summary Covista is trading significantly below its intrinsic value despite short-term headwinds at Chamberlain University. All segments are growing revenue; Walden University’s 27% revenue and 13% enrollment growth offset Chamberlain’s 1% enrollment decline. Key risks include heavy reliance on Title IV funding and regulatory changes, though long-term healthcare demand and AI-driven career shifts support growth and limit risk. Read the full article on Seeking AlphaAnaliz Makalesi • Sep 27
With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analiz Makalesi • Aug 07
Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet
NYSE:ATGE 1 Year Share Price vs Fair Value Explore Adtalem Global Education's Fair Values from the Community and select...Analiz Makalesi • Jul 07
An Intrinsic Calculation For Adtalem Global Education Inc. (NYSE:ATGE) Suggests It's 44% Undervalued
Key Insights Adtalem Global Education's estimated fair value is US$221 based on 2 Stage Free Cash Flow to Equity...Analiz Makalesi • May 13
There's Reason For Concern Over Adtalem Global Education Inc.'s (NYSE:ATGE) Massive 27% Price Jump
Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders have had their patience rewarded with a 27% share price jump...Analiz Makalesi • May 07
If EPS Growth Is Important To You, Adtalem Global Education (NYSE:ATGE) Presents An Opportunity
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analiz Makalesi • Apr 24
Is Adtalem Global Education (NYSE:ATGE) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analiz Makalesi • Mar 25
Adtalem Global Education Inc. (NYSE:ATGE) Shares Could Be 48% Below Their Intrinsic Value Estimate
Key Insights Adtalem Global Education's estimated fair value is US$198 based on 2 Stage Free Cash Flow to Equity...Analiz Makalesi • Mar 11
Subdued Growth No Barrier To Adtalem Global Education Inc.'s (NYSE:ATGE) Price
With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for...Analiz Makalesi • Feb 24
Is There Now An Opportunity In Adtalem Global Education Inc. (NYSE:ATGE)?
Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it saw a decent share price...Seeking Alpha • Feb 21
Adtalem Global Education: Surging On Registered Nurse Shortage
Summary Adtalem Global Education Inc.'s financial performance has surged with an underlying nationwide shortage of Registered Nurses and in mental health professionals. A shortage is expected to persist — Adtalem still looks to benefit from secular trends in an aging population, while the long-term performance depends on universities' ability to expand capacity. ATGE stock's surge already reflects a good mid-term earnings performance, making long-term growth required for significant returns. I estimate a fair value of $109.5. Read the full article on Seeking AlphaAnaliz Makalesi • Jan 21
With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analiz Makalesi • Dec 19
These 4 Measures Indicate That Adtalem Global Education (NYSE:ATGE) Is Using Debt Reasonably Well
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Seeking Alpha • Dec 17
Adtalem Global Education Still Offers Competitive PEG Ratio And Substantial Share Buybacks
Summary The company has shown significant financial progress with improving EBIT and profit margins, indicating efficient cost management. Current valuation metrics suggest the company is rather cheaply priced, despite the good run in 2024. The future outlook remains positive, but investors should be aware of potential risks, such as the debt or future competitive threats from robotics. Read the full article on Seeking AlphaAnaliz Makalesi • Nov 26
Adtalem Global Education Inc.'s (NYSE:ATGE) Shares Climb 27% But Its Business Is Yet to Catch Up
Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders would be excited to see that the share price has had a great...Analiz Makalesi • Oct 31
Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?
Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it led the NYSE gainers with a...Analiz Makalesi • Oct 16
Should You Be Adding Adtalem Global Education (NYSE:ATGE) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Seeking Alpha • Oct 04
Adtalem Global Education Faces Problems But Is Growing Steadily
Summary Adtalem Global Education focuses on medical and veterinary education, showing solid profitability and potential growth in a booming healthcare industry. Despite a current ratio below 1.0, ATGE maintains a reasonable price/book ratio and generates significant operating cash flow, indicating financial stability. Risks include reliance on government financial aid, maintaining accreditation, and ensuring student placements in healthcare jobs, which are crucial for sustaining reputation and revenue. With projected revenue growth and a forward P/E ratio of 13.12, Adtalem Global is a cautious buy, offering portfolio diversity in a growing sector. Read the full article on Seeking AlphaAnaliz Makalesi • Sep 16
Adtalem Global Education (NYSE:ATGE) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analiz Makalesi • Aug 29
Adtalem Global Education Inc.'s (NYSE:ATGE) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 20.7x Adtalem Global Education Inc. ( NYSE:ATGE ) may be sending bearish...Analiz Makalesi • Aug 14
We Think Adtalem Global Education's (NYSE:ATGE) Robust Earnings Are Conservative
Even though Adtalem Global Education Inc.'s ( NYSE:ATGE ) recent earnings release was robust, the market didn't seem to...Analiz Makalesi • Jul 28
Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?
While Adtalem Global Education Inc. ( NYSE:ATGE ) might not have the largest market cap around , it led the NYSE...Seeking Alpha • Jul 27
Adtalem Global Education: Still Undervalued After The Latest Rally
Summary Adtalem Global Education is set to report earnings on August 6th. The company specializes in healthcare education, with Chamberlain and Walden Universities under its wing, showing revenue growth post Walden acquisition. Financials show decent margins, but efficiency metrics trending down, with potential for top-line growth and margin expansion in the future. Read the full article on Seeking AlphaAnaliz Makalesi • Jul 12
Does Adtalem Global Education (NYSE:ATGE) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analiz Makalesi • Jun 14
Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • May 19
Adtalem Global Education: A Leading Healthcare Educator In A Growing Industry
Summary ATGE has demonstrated robust revenue growth and strong profit margins over the past three years. ATGE's 3Q24 earnings showed year-over-year revenue growth of 11.8%, driven by growth in enrollment and tuition rates. The healthcare industry is facing significant labour shortages, which are expected to impact hospitals growth targets and outlook. ATGE plays a crucial role in training and providing healthcare professionals. Read the full article on Seeking AlphaCEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$250m |
| Dec 31 2025 | n/a | n/a | US$254m |
| Sep 30 2025 | n/a | n/a | US$247m |
| Jun 30 2025 | US$17m | US$1m | US$233m |
| Mar 31 2025 | n/a | n/a | US$229m |
| Dec 31 2024 | n/a | n/a | US$204m |
| Sep 30 2024 | n/a | n/a | US$172m |
| Jun 30 2024 | US$14m | US$987k | US$138m |
| Mar 31 2024 | n/a | n/a | US$111m |
| Dec 31 2023 | n/a | n/a | US$122m |
| Sep 30 2023 | n/a | n/a | US$108m |
| Jun 30 2023 | US$8m | US$950k | US$102m |
| Mar 31 2023 | n/a | n/a | US$79m |
| Dec 31 2022 | n/a | n/a | US$35m |
| Sep 30 2022 | n/a | n/a | US$47m |
| Jun 30 2022 | US$9m | US$828k | -US$36m |
| Mar 31 2022 | n/a | n/a | -US$35m |
| Dec 31 2021 | n/a | n/a | -US$15m |
| Sep 30 2021 | n/a | n/a | -US$26m |
| Jun 30 2021 | US$3m | US$600k | US$63m |
| Mar 31 2021 | n/a | n/a | US$139m |
| Dec 31 2020 | n/a | n/a | US$269m |
| Sep 30 2020 | n/a | n/a | US$246m |
| Jun 30 2020 | US$2m | US$598k | US$220m |
| Mar 31 2020 | n/a | n/a | US$208m |
| Dec 31 2019 | n/a | n/a | US$89m |
| Sep 30 2019 | n/a | n/a | US$130m |
| Jun 30 2019 | US$2m | US$536k | US$107m |
Tazminat ve Piyasa: Steve 'nin toplam tazminatı ($USD 17.24M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 7.00M ).
Tazminat ve Kazançlar: Steve 'in maaşı son bir yılda %20'den fazla arttı.
CEO
Steve Beard (54 yo)
4.7yrs
Görev süresi
US$17,244,988
Tazminat
Mr. Stephen W. Beard, also known as Steve, J.D., serves as an Independent Director at Planet Fitness, Inc. since February 9, 2026. He served as Chief Operating Officer at Adtalem Global Education Inc. sinc...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Chairman | 4.7yrs | US$17.24m | 1.08% $ 45.5m | |
| Senior VP & CFO | 5.1yrs | US$2.02m | 0.13% $ 5.7m | |
| Senior VP of Institutional Support Services | 4.9yrs | US$1.65m | 0.096% $ 4.1m | |
| Chief Growth & Innovation Officer and President of Walden University | 4yrs | US$2.59m | 0.069% $ 2.9m | |
| President of Adtalem Medical & Veterinary | 2.1yrs | US$1.62m | 0.022% $ 919.4k | |
| VP & Chief Accounting Officer | 4.1yrs | Veri yok | 0.0063% $ 266.9k | |
| Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Senior VP & Chief Human Resources Officer | 1.7yrs | Veri yok | 0.0083% $ 349.3k | |
| Senior VP & Chief Corporate Affairs Officer | 1yr | Veri yok | Veri yok | |
| President of Chamberlain University | no data | Veri yok | Veri yok | |
| President of Chamberlain University | 7.8yrs | US$1.14m | 0.083% $ 3.5m | |
| Vice President of Treasury & Risk Management | no data | Veri yok | Veri yok |
4.1yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: CVSA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.1 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Chairman | 4.7yrs | US$17.24m | 1.08% $ 45.5m | |
| Director Emeritus | no data | US$108.37k | Veri yok | |
| Director Emeritus | 12.5yrs | US$95.00k | Veri yok | |
| Independent Director | 9.3yrs | US$250.17k | 0.026% $ 1.1m | |
| Lead Independent Director | 9.9yrs | US$251.42k | 0.41% $ 17.2m | |
| Independent Director | 6.1yrs | US$225.17k | 0.054% $ 2.3m | |
| Independent Director | 7.6yrs | US$237.67k | 0.020% $ 841.6k | |
| Director | 17.5yrs | US$273.17k | 0.13% $ 5.3m | |
| Independent Director | 6.1yrs | US$237.67k | 0.040% $ 1.7m | |
| Independent Director | 2.3yrs | US$225.17k | 0.0034% $ 141.7k | |
| Independent Director | 8yrs | US$237.67k | 0.047% $ 2.0m | |
| Independent Director | 3.9yrs | US$225.17k | 0.044% $ 1.8m |
7.6yrs
Ortalama Görev Süresi
66yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: CVSA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.6 yıldır).
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/27 06:29 |
| Gün Sonu Hisse Fiyatı | 2026/05/27 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/06/30 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Covista Inc. 23 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Gary Bisbee | Barclays |
| Alexander Paris | Barrington Research Associates, Inc. |
| Jeffrey Silber | BMO Capital Markets Equity Research |